O'Shaughnessy Asset Management’s Surmodics SRDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-265
Closed -$15K 2323
2021
Q3
$15K Hold
265
﹤0.01% 2043
2021
Q2
$14K Buy
+265
New +$14.5K ﹤0.01% 1923
2018
Q4
Sell
-1,368
Closed -$101K 1013
2018
Q3
$101K Buy
+1,368
New +$94.2K ﹤0.01% 645
2017
Q4
Sell
-5,923
Closed -$184K 996
2017
Q3
$184K Buy
5,923
+1,082
+22% +$29.4K ﹤0.01% 530
2017
Q2
$136K Hold
4,841
﹤0.01% 584
2017
Q1
$116K Sell
4,841
-13
-0.3% -$319 ﹤0.01% 601
2016
Q4
$123K Buy
+4,854
New +$128K ﹤0.01% 605
2014
Q1
Sell
-29,525
Closed -$718K 1060
2013
Q4
$718K Sell
29,525
-8,212
-22% -$194K 0.02% 373
2013
Q3
$895K Sell
37,737
-12,164
-24% -$261K 0.02% 338
2013
Q2
$1M Buy
+49,901
New +$1.25M 0.03% 314

Other funds holding SRDX

O'Shaughnessy Asset Management's SRDX Position: Q4 2021 in Review

O'Shaughnessy Asset Management sold out of Surmodics (SRDX) in Q4 2021, closing a stake of 265 shares — an estimated $15K sold.

O'Shaughnessy Asset Management first reported a position in SRDX in Q2 2013 and held it in 10 quarters. The position peaked at $1M in Q2 2013. 148 funds tracked by Wall St. Rank hold SRDX as of Q4 2021.

  • O'Shaughnessy Asset Management reported no remaining Surmodics position as of Q4 2021 after selling out during the quarter.
  • O'Shaughnessy Asset Management sold 265 Surmodics shares in Q4 2021, an estimated $15K.
  • O'Shaughnessy Asset Management first reported a position in Surmodics in Q2 2013 and held it in 10 quarters.
  • O'Shaughnessy Asset Management's Surmodics position peaked at $1M in Q2 2013.
  • 148 funds tracked by Wall St. Rank held Surmodics as of Q4 2021.

Based on O'Shaughnessy Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.